Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Sep;74(3):220–223. doi: 10.1136/hrt.74.3.220

Reversible ischaemia in hypertrophic cardiomyopathy.

H Thomson 1, W Fong 1, W Stafford 1, M Frenneaux 1
PMCID: PMC484009  PMID: 7547013

Abstract

Atypical and typical chest pains are common symptoms in patients with hypertrophic cardiomyopathy. Some of these chest pains seem to be caused by ischaemia. It is difficult to objectively demonstrate ischaemia in hypertrophic cardiomyopathy. The first line treatment for chest pain considered to be ischaemic in patients with hypertrophic cardiomyopathy is the use of either a beta blocker or calcium blocker. Septal myectomy can be effective in patients with symptoms refractory to conventional treatment but is associated with significant morbidity and mortality. Recently dual chamber pacing has been advocated in such patients. In some cases dual chamber pacing alleviates chest pain in hypertrophic cardiomyopathy by an anti-ischaemic action, presumably by reducing the left ventricular outflow tract gradient and perhaps by causing an associated decrease in left ventricular outflow tract gradient and perhaps by causing an associated decrease in left ventricular end diastolic pressure.

Full text

PDF
220

Images in this article

221Image
on p.221
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnew T. M., Barratt-Boyes B. G., Brandt P. W., Roche A. H., Lowe J. B., O'Brien K. P. Surgical resection in idiopathic hypertrophic subaortic stenosis with a combined approach through aorta and left ventricle. J Thorac Cardiovasc Surg. 1977 Aug;74(2):307–316. [PubMed] [Google Scholar]
  2. Cannon R. O., 3rd, Dilsizian V., O'Gara P. T., Udelson J. E., Schenke W. H., Quyyumi A., Fananapazir L., Bonow R. O. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 1991 May;83(5):1660–1667. doi: 10.1161/01.cir.83.5.1660. [DOI] [PubMed] [Google Scholar]
  3. Cannon R. O., 3rd, Rosing D. R., Maron B. J., Leon M. B., Bonow R. O., Watson R. M., Epstein S. E. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation. 1985 Feb;71(2):234–243. doi: 10.1161/01.cir.71.2.234. [DOI] [PubMed] [Google Scholar]
  4. Codd M. B., Sugrue D. D., Gersh B. J., Melton L. J., 3rd Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989 Sep;80(3):564–572. doi: 10.1161/01.cir.80.3.564. [DOI] [PubMed] [Google Scholar]
  5. Dilsizian V., Bonow R. O., Epstein S. E., Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993 Sep;22(3):796–804. doi: 10.1016/0735-1097(93)90193-5. [DOI] [PubMed] [Google Scholar]
  6. Fananapazir L., Cannon R. O., 3rd, Tripodi D., Panza J. A. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 1992 Jun;85(6):2149–2161. doi: 10.1161/01.cir.85.6.2149. [DOI] [PubMed] [Google Scholar]
  7. Frank S., Braunwald E. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation. 1968 May;37(5):759–788. doi: 10.1161/01.cir.37.5.759. [DOI] [PubMed] [Google Scholar]
  8. Gulotta S. J., Hamby R. I., Aronson A. L., Ewing K. Coexistent idiopathic hypertrophic subaortic stenosis and coronary arterial disease. Circulation. 1972 Nov;46(5):890–896. doi: 10.1161/01.cir.46.5.890. [DOI] [PubMed] [Google Scholar]
  9. Hubner P. J., Ziady G. M., Lane G. K., Hardarson T., Scales B., Oakley C. M., Goodwin J. F. Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J. 1973 Nov;35(11):1116–1123. doi: 10.1136/hrt.35.11.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jeanrenaud X., Goy J. J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992 May 30;339(8805):1318–1323. doi: 10.1016/0140-6736(92)91961-7. [DOI] [PubMed] [Google Scholar]
  11. Kaltenbach M., Hopf R. Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms. J Mol Cell Cardiol. 1985 Jul;17 (Suppl 2):59–68. doi: 10.1016/0022-2828(85)90009-4. [DOI] [PubMed] [Google Scholar]
  12. Kostis J. B., Moreyra A. E., Natarajan N., Hosler M., Kuo P. T., Conn H. L., Jr The pathophysiology and diverse etiology of septal perforator compression. Circulation. 1979 May;59(5):913–919. doi: 10.1161/01.cir.59.5.913. [DOI] [PubMed] [Google Scholar]
  13. Maron B. J., Epstein S. E., Roberts W. C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979 Jun;43(6):1086–1102. doi: 10.1016/0002-9149(79)90139-5. [DOI] [PubMed] [Google Scholar]
  14. McKenna W. J., Borggrefe M., England D., Deanfield J., Oakley C. M., Goodwin J. F. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation. 1982 Dec;66(6):1233–1240. doi: 10.1161/01.cir.66.6.1233. [DOI] [PubMed] [Google Scholar]
  15. Nienaber C. A., Gambhir S. S., Mody F. V., Ratib O., Huang S. C., Phelps M. E., Schelbert H. R. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation. 1993 May;87(5):1580–1590. doi: 10.1161/01.cir.87.5.1580. [DOI] [PubMed] [Google Scholar]
  16. O'Gara P. T., Bonow R. O., Maron B. J., Damske B. A., Van Lingen A., Bacharach S. L., Larson S. M., Epstein S. E. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation. 1987 Dec;76(6):1214–1223. doi: 10.1161/01.cir.76.6.1214. [DOI] [PubMed] [Google Scholar]
  17. Pitcher D., Wainwright R., Maisey M., Curry P., Sowton E. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J. 1980 Dec;44(6):650–656. doi: 10.1136/hrt.44.6.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sanderson J. E., Traill T. A., Sutton M. G., Brown D. J., Gibson D. G., Goodwin J. F. Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J. 1978 Jun;40(6):596–601. doi: 10.1136/hrt.40.6.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sutton M. G., Tajik A. J., Smith H. C., Ritman E. L. Angina in idiopathic hypertrophic subaortic stenosis. A clinical correlate of regional left ventricular dysfunction: a videometric and echocardiographic study. Circulation. 1980 Mar;61(3):561–568. doi: 10.1161/01.cir.61.3.561. [DOI] [PubMed] [Google Scholar]
  20. Takata J., Counihan P. J., Gane J. N., Doi Y., Chikamori T., Ozawa T., McKenna W. J. Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol. 1993 Jul 15;72(2):211–217. doi: 10.1016/0002-9149(93)90162-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES